Read the latest research on
neurological disorders and iTMS therapy.
The latest U.S. Centers for Disease Control and Prevention (CDC) study identified 1 in 88 American children (1 in 54 boys) have autism spectrum disorders (ASD). The ratio of males to females is 4:1. This is a ten-fold increase in prevalence over the last 40 years. There are over 2 million cases in the US.
According to the Harvard School of Public Health, the cost to care for a child with autism is estimated at $3.2 million dollars over the child’s lifetime. In 2012, the annual cost in the US was $250 billion. To a great extent, this was funded by tax dollars with approximately 90% of costs for adult services (i.e. assisted living, medical, etc). Harvard School of Public Health; Ganz (2006)
At the 2014 Autism One conference, the results of a 12-week randomized controlled trial of 24 autistic children, done by Dr. Jeff Bradstreet under the auspices of the Brain Treatment Center, were released showing that an individualized Transcranial Magnetic Stimulation (iTMS) protocol could dramatically improve autism with slightly less than half the children achieving a neuro-typical rating by Child Autism Rating Scale, and another quarter achieving a 30% improvement in their scores. These results open a new frontier for reversing autistic symptoms.